Dott.ssa Cristina Falci
LISTof publications with IF
Total IF: 167,953 (2013 Journal of Citation Report Institute of Scientific
Information)
Total H Index : 10 (Harzing’s index 2013)
Eur J ClinMicrobiolInfectDis.
The Lancet
Int. J.Med. Sci
GynecolOncol.
Anticancer Res
Eur J Cancer
CritRevOncolHematol
Tumori
AgeingHealth
RecentPatAnticancerDrugDiscov
CancerTreat Rev.
Lancet Oncol
Journal of ClinicalOncology
InternEmergMed
J Bone MinerMetab
Br J Cancer.
BreastCancer Res Treat.
AnnOncol.
J GeriatrOncology
TOT IF
3,024
39,06
2,065
3,929
1,713
5,061
4,637
0,922
1,695
2,7
6,024
21,856
18,038
2,345
2,219
5,082
4,469
7,384
1,118
28
1
1
1
1
5
1
2
1
4
1
1
1
2
1
1
1
1
1
1
3,024
39,06
2,065
3,929
8,565
5,061
9,274
0,922
6,78
2,7
6,024
21,856
36,076
2,345
2,219
5,082
4,469
7,384
1,118
167,953
List of PAPERS (Peer Reviewed Journals)
1. Valisena S, Falci C, Mazzariol A et al. Molecular typing of erytromycin-resistant
Streptococcus pyogenes strains with the M phenotype isolated in Italy. Eur J Clin
Microbiol Infect Dis. 1999; 18(4): 260-266.
2. Parmar M.K., Ledermann J.A., Colombo N. and ICON AGO collaborators.
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based
chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR
2.2 trial. The Lancet 2003; 362: 1504.
3. M.O. Nicoletto, S. Tumolo, C. Falci and the GOCCNE Group (Gruppo
Oncologico Cooperativo Clinico Nord-Est ovaio), Padua, Italy. A Randomized
Study of Epithelial Ovarian Cancer: Is Chemotherapy Useful after Complete
Remission? Int. J. Med. Sci. 2004; 1(2): 116-125.
4. Jirillo A., Falci C. Questionable methods in cancer therapy. Rec. Prog Med. 2005;
96(7-8):344-51.
5. Nicoletto MO, Falci C, Pianalto D, Artioli G, Azzoni P, De Masi G, Ferrazzi E,
Perin A, Donach M, Zoli W. Phase II study of pegylated liposomal doxorubicin
and oxaliplatin in relapsed advanced ovarian cancer. Gynecol Oncol. 2006;
100(2):318-23.
6. Pasetto LM, Friso ML, Pucciarelli S, Basso U, Falci C, Bortolami A, Toppan P,
Agostini M, Rugge M, Serpentini S, Nitti D, Monfardini S. Rectal cancer
neoadjuvant treatment in elderly patients. Anticancer Res. 2006; 26(5B):3913-23.
7. Pasetto LM, Bortolami A, Falci C, Sinigaglia G, Monfardini S. Recent progress in
target therapy in colorectal cancer. Anticancer Res. 2006; 26(5B):3973-81.
8. Pasetto LM, Falci C, Compostella A, Sinigaglia G, Rossi E, Monfardini S. Quality
of life in elderly cancer patients. Eur J Cancer, 2007; 43: 1508-1513.
9. Pasetto LM; D’Andrea MR, Falci C, Monfardini S. Gemcitabine in advanced
biliary tract cancers. Crit Rev Oncol Hematol. 2007; 61(3):230-42.
10. Nicoletto MO, Donach M, Borgato L, Falci C, Zanin L, De Masi G. Lack of
cardiotoxicity with liposomal doxorubicin in an elderly case of ovarian cancer.
Tumori, 2007; 93(2):204-6.
11. Pasetto LM, Falci C, Basso U, Gasparini G, D'Andrea M, Bonginelli P, Bajetta E,
Platania M, Alabisio O, Miraglia S, Bertona E, Oniga F, Biason R, Chetrì MC,
Fedele P, Massara G, Romaniello I, Negru ME, Giordano M, Luchena G, Buzzi
F, Ricotta R, Siena S, Monfardini S. Colorectal cancer treatment in elderly
patients: results of a retrospective analysis addressed to the chiefs of medical
oncology units in Italy. Anticancer Res, 2007; 27(5B):3601-8.
12. Basso U, Tonti S, Bassi C, Brunello A, Pasetto LM, Scaglione D, Falci C, Beda
M, Aversa SM, Stefani M, Castegnaro E, Tamellini F, Monfardini S. Management
of Frail and Not-Frail elderly cancer patients in a hospital-based Geriatric
Oncology Program. Crit Rev Oncol Hematol, 2008; 6(2):163-70.
13. Pasetto LM, Jirillo A, Lonardi S, Falci C and Monfardini S. Colon cancer in
elderly patients: what the best treatment? Ageing Health, 2008; 4: 279-286.
14. Brunello A, Jirillo A, Falci C, Basso U and Monfardini S. Treatment of advanced
breast cancer in elderly women. Ageing Health, 2008; 4: 267-277.
15. Falci C, Brunello A, Basso U, Roma A and Monfardini S. Medical approach to
advanced prostate cancer in older patients. Aging Health, 2008; 4: 481-494.
16. Pasetto LM, Falci C, Basso U, Gasparini G, D'Andrea M, Bonginelli P, Bajetta E,
Platania M, Alabiso O, Miraglia S, Bertona E, Oniga F, Biason R, Chetrì MC,
Fedele P, Massara G, Romaniello I, Negru ME, Luchena G, Giordano M, Buzzi
F,Ricotta R, Sienao S, Monfardini S. Adjuvant treatment for elderly patients with
colon cancer. An observational study. Anticancer Res. 2008; 28(4C):2513-8.
17. Pasetto LM, Falci C, Rizzo E, De Salvo GL, Gasparini G, D'Andrea M, Bajetta E,
Platania M, Alabiso O, Miraglia S, Oniga F, Biason R, Chetrì MC, Fedele P,
Massara G, Romaniello I, Giordano M, Luchena G, Buzzi F, Ricotta R, Siena S,
Monfardini S. Palliative Treatment for Elderly Patients with Colon Cancer in Ten
Italian Medical Oncology Units. Anticancer Res 2008; 28: 1813-1820.
18. Brunello A, Roma A, Falci C, Basso U. Chemotherapy and targeted agents for
elderly women with advanced breast cancer. Recent Pat Anticancer Drug Discov.
2008; 3(3):187-201.
19. Falci C, Morello E, Droz JP. Treatment of prostate cancer in unfit senior adult
patients. Cancer Treat Rev. 2009 Oct;35(6):522-7.
20. Morello E, Giordano G, Falci C and Monfardini S. Rehabilitation in older cancer
patients. Ageing&Health 2009; 5(3): 369-384.
21. Agnelli G, Gussoni G, Bianchini C, Verso M, Mandalà M, Cavanna L, Barni S,
Labianca R, Buzzi F, Scambia G, Passalacqua R, Ricci S, Gasparini G, Lorusso V,
Bonizzoni E, Tonato M; PROTECHT Investigators. Nadroparin for the prevention
of thromboembolic events in ambulatory patients with metastatic or locally
advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled,
double-blind study. Lancet Oncol. 2009 Oct;10(10):943-9. Epub 2009 Aug 31.
22. Falci C, Brunello A, Monfardini S. Detecting functional impairment in older
patients with cancer: is Vulnerable Elders Survey-13 the right pre-screening tool?
A still open question. Journal of Clinical Oncology, 30.06.2010.
23. Monfardini S, Falci C, Brunello A, Lonardi S, Basso U. Cancer in the elderly.
Intern Emerg Med. 2011 Oct;6 Suppl 1:115-8. Review.
24. Cristina Falci, Antonella Brunello, and Silvio Monfardini. Reply to M.J. MolinaGarrido et al. Journal of Clinical Oncology, Aug 10, 2011:3202.
25. Sergi G, Pintore G, Falci C, Veronese N, Berton L, Perissinotto E, Basso U,
Brunello A, Monfardini S, Manzato E, Coin A. Preventive effect of risedronate on
bone loss and frailty fractures in elderly women treated with anastrozole for early
breast cancer. J Bone Miner Metab (2012) 30:461–467.
26. Monfardini S, Basso U, Fiduccia P, Crivellari D, Molino AM, Falci C. Adjuvant!
Online or comprehensive geriatric assessment for women over 70 years with
primary breast cancer? Br J Cancer. 2012 Mar 13;106(6):1247.
27. Campana LG, Valpione S, Falci C, Mocellin S, Basso M, Corti L, Balestrieri N,
Marchet A, Rossi CR. The activity and safety of electrochemotherapy in persistent
chest wall recurrence from breast cancer after mastectomy: a phase-II study.
Breast Cancer Res Treat. 2012 Aug;134(3):1169-78.
28. Brunello A, Basso U, Sacco C, Sava T, De Vivo R, Camerini A, Barile C, Roma
A, Maruzzo M, Falci C, Zagonel V. Safety and activity of sunitinib in elderly
patients (≥ 70 years) with metastatic renal cell carcinoma: a multicenter study.
Ann Oncol. 2013 Feb;24(2):336-42.
29. V. Giantin, E. Valentini, M. Iasevoli, C. Falci, P. Siviero, E. De Luca, S. Maggi,
B. Martella, G. Orrù, G. Crepaldi, S. Monfardini, O. Terranova, E. Manzato. Does
the Multidimensional Prognostic Index (MPI), based on a Comprehensive
Geriatric Assessment (CGA), predict mortality in cancer patients? Results of a
prospective observational trial. J Geriatr Oncology – accepted for publication,
2013.